HomeRTGN • OTCMKTS
add
RetinalGenix Technologies Inc
Previous close
$3.20
Year range
$2.01 - $6.36
Market cap
59.54M USD
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 567.83K | -11.74% |
Net income | -568.79K | 11.72% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -567.83K | 11.73% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 92.00 | -99.88% |
Total assets | 7.00K | -92.12% |
Total liabilities | 2.18M | 12.17% |
Total equity | -2.17M | — |
Shares outstanding | 18.60M | — |
Price to book | -26.67 | — |
Return on assets | -18,450.53% | — |
Return on capital | 95.73% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -568.79K | 11.72% |
Cash from operations | -103.84K | 57.95% |
Cash from investing | — | — |
Cash from financing | 103.09K | -56.89% |
Net change in cash | -747.00 | 90.45% |
Free cash flow | 131.15K | 4,038.56% |
About
Founded
2017
Headquarters
Website
